We are live on ! Find out more
CIA

CCM Investment Advisers Portfolio holdings

AUM $1.04B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+40.82%
3 Year Est. Return
+117.67%
5 Year Est. Return
+151.7%
10 Year Est. Return
+485.69%
AUM
$745M
AUM Growth
+$38.2M
Cap. Flow
-$5.06M
Cap. Flow %
-0.68%
Top 10 Hldgs %
27.7%
Holding
72
New
2
Increased
31
Reduced
29
Closed
3

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$6.56M
2
CVS icon
CVS Health
CVS
+$1.38M
3
QCOM icon
Qualcomm
QCOM
+$1.1M
4
RTX icon
RTX Corp
RTX
+$892K
5
UNH icon
UnitedHealth
UNH
+$831K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.81M
2
NVDA icon
NVIDIA
NVDA
+$4.52M
3
MSFT icon
Microsoft
MSFT
+$2.02M
4
AAPL icon
Apple
AAPL
+$1.96M
5
AVGO icon
Broadcom
AVGO
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 30.03%
2 Healthcare 14.15%
3 Financials 11.61%
4 Consumer Discretionary 11.54%
5 Industrials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$435B
$12.6M 1.69%
93,409
+3,289
+4% +$482K
UPS icon
27
United Parcel Service
UPS
$88.9B
$12.5M 1.68%
69,864
+1,139
+2% +$202K
RTX icon
28
RTX Corp
RTX
$301B
$12.4M 1.66%
126,507
+9,107
+8% +$892K
BMY icon
29
Bristol-Myers Squibb
BMY
$132B
$12.2M 1.63%
190,325
+8,063
+4% +$541K
SO icon
30
Southern Company
SO
$107B
$11.8M 1.58%
168,010
+683
+0.4% +$49K
CVS icon
31
CVS Health
CVS
$122B
$11.6M 1.55%
167,148
+19,335
+13% +$1.38M
GILD icon
32
Gilead Sciences
GILD
$165B
$11.5M 1.54%
148,594
+5,633
+4% +$449K
MPC icon
33
Marathon Petroleum
MPC
$83.7B
$11.1M 1.49%
95,437
-192
-0.2% -$22.3K
ALL icon
34
Allstate
ALL
$67.5B
$10.9M 1.46%
99,530
-496
-0.5% -$56.3K
EVR icon
35
Evercore
EVR
$11.8B
$10.7M 1.44%
86,968
+71
+0.1% +$8.17K
NUE icon
36
Nucor
NUE
$62.1B
$10.7M 1.44%
65,321
+175
+0.3% +$25.6K
CB icon
37
Chubb
CB
$135B
$10.7M 1.44%
55,620
-372
-0.7% -$72.9K
CVX icon
38
Chevron
CVX
$366B
$10.7M 1.44%
67,970
-1,492
-2% -$239K
SHW icon
39
Sherwin-Williams
SHW
$89.8B
$10.7M 1.43%
40,215
+590
+1% +$139K
PEP icon
40
PepsiCo
PEP
$190B
$10.6M 1.42%
57,195
-241
-0.4% -$45K
QCOM icon
41
Qualcomm
QCOM
$176B
$10.4M 1.4%
87,646
+9,598
+12% +$1.1M
O icon
42
Realty Income
O
$59.1B
$10.3M 1.39%
172,855
+4,548
+3% +$278K
WMT icon
43
Walmart Inc
WMT
$890B
$10.2M 1.37%
194,448
-1,083
-0.6% -$54.6K
PLD icon
44
Prologis
PLD
$133B
$10.1M 1.35%
82,060
+2,258
+3% +$278K
BAC icon
45
Bank of America
BAC
$442B
$9.83M 1.32%
342,713
-1,175
-0.3% -$33.5K
PSX icon
46
Phillips 66
PSX
$81.4B
$9.69M 1.3%
101,562
+1,330
+1% +$129K
PG icon
47
Procter & Gamble
PG
$339B
$9.25M 1.24%
60,966
-709
-1% -$107K
COF icon
48
Capital One
COF
$134B
$9.07M 1.22%
82,971
-3,363
-4% -$337K
STX icon
49
Seagate
STX
$184B
$9M 1.21%
145,485
+5,132
+4% +$313K
DIS icon
50
Walt Disney
DIS
$181B
$8.73M 1.17%
97,746
+4,691
+5% +$444K

Similar funds

CCM Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, CCM Investment Advisers held 72 positions worth $745M, up 5.4% from $706M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CCM Investment Advisers's Q2 2023 filing shows 2 new, 31 increased, 29 reduced and 3 closed positions. Its largest new stake was Abbott: 61,539 shares worth $6.71M. The largest sale was Pfizer, an estimated $4.81M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • CCM Investment Advisers's largest Q2 2023 buy was Abbott: 61,539 shares worth $6.71M.
  • CCM Investment Advisers added most to CVS Health in Q2 2023, an estimated $1.38M increase.
  • CCM Investment Advisers's biggest Q2 2023 reduction was Pfizer, cutting an estimated $4.81M.
  • CCM Investment Advisers fully exited Zebra Technologies in Q2 2023, selling an estimated $653K.
  • CCM Investment Advisers's ten largest holdings make up 28% of its $745M portfolio in Q2 2023.
  • CCM Investment Advisers opened 2 new positions and closed 3 in Q2 2023.
  • CCM Investment Advisers's portfolio value rose 5.4% quarter-over-quarter to $745M.

Based on CCM Investment Advisers's 13F filing for Q2 2023, filed 21 Aug 2023.